Quince Therapeutics, Inc. (QNCX): S-3 filed Jul 31, 2026

Form type

S-3

Filing date

Jul 31, 2026

Accession number

0001193125-26-328769

Filer

Quince Therapeutics, Inc. (CIK 1662774)